搜索临床试验以:B 部分:TRV250 第 3 剂
总计1286个结果
-
Lawrence D RechtSanofi主动,不招人
-
Memorial Sloan Kettering Cancer CenterNYU Langone Health; National Comprehensive Cancer Network; New York University Cancer Institute完全的
-
Pfizer完全的斑秃中国, 美国, 西班牙, 大韩民国, 台湾, 加拿大, 澳大利亚, 德国, 捷克语, 波兰, 匈牙利, 日本, 英国, 阿根廷, 智利, 哥伦比亚, 墨西哥, 俄罗斯联邦
-
ANRS, Emerging Infectious DiseasesInstitut National de la Santé Et de la Recherche Médicale, France完全的
-
Alexza Pharmaceuticals, Inc.Atlanta Center for Medical Research完全的
-
National Institute of Diabetes and Digestive and...招聘中
-
National Cancer Institute (NCI)主动,不招人
-
University of PittsburghDalhousie University; National Institute on Disability, Independent Living, and Rehabilitation...招聘中
-
Kyunghee University Medical CenterKyungHee University School of Medicine, Korea完全的
-
Washington University School of MedicineThe Task Force for Global Health; Murdoch Children's Research Institute完全的
-
Sanofi Pasteur, a Sanofi Company完全的百日咳免疫 | 白喉免疫 | 破伤风免疫 | 肺炎球菌免疫 | 乙型肝炎免疫 | 脊髓灰质炎免疫 | B型流感嗜血杆菌免疫 | 轮状病毒免疫泰国
-
Rockefeller UniversityBrigham and Women's Hospital; Weill Medical College of Cornell University; University of Cologne完全的
-
Shanxi Medical UniversityCenters for Disease Control and Prevention, China完全的乙型肝炎疫苗接种
-
AstraZeneca完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人
-
Regeneron Pharmaceuticals主动,不招人
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI)完全的
-
Suping WangCenters for Disease Control and Prevention, China完全的乙型肝炎疫苗
-
University of North Carolina, Chapel HillBurroughs Wellcome; The American Society of Tropical Medicine and Hygiene完全的
-
Clementia Pharmaceuticals Inc.完全的
-
University of ManitobaJohns Hopkins University; University Health Network, Toronto; University of California, Berkeley; University of California, San Diego 和其他合作者招聘中